Value202020212022202320242025TTMCash from investing activities———5.42 M355.13 M16.34 M16.34 MCash from financing activities———34.35 M343.88 M12.37 M12.37 MFree cash flow———-2.48 M20.89 M6.37 M6.37 M
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.